01/29/2014 | Richard Gallagher
Ranking the 100 most influential people in ophthalmology. Which clinicians and researchers have the biggest impact on our field?
01/21/2014 | Irv Arons, Mark Hillen
The EMA approved the first gene therapy agent in 2012 – for lipoprotein lipase deficiency. Might gene therapies for ophthalmic disease reach the wards any time soon?
01/20/2014 | Mark Hillen
Americans love their cars and in many places you’re virtually stranded if you don’t drive. So does vision loss stop elderly Americans from driving?
The pupil of the eye is dark, and the cornea highly reflective – it acts as a mirror. Combine this with high resolution photography, and you get a whole new vista.
The media have been building up “eyeball jewelry” as a potential craze, but the evidence suggests otherwise
12/04/2013
Expert opinion: infection prevention & treatment in photorefractive surgery patients.
12/03/2013 | Irv Arons, Mark Hillen
Therapies based on stem cell treatments are considered to have tremendous potential in medicine.
12/02/2013 | Richard Gallagher
Five questions that must be answered on the causes and consequences of near-sightedness.
12/02/2013 | Mark Hillen
The AAO are encouraging diabetics to do something to protect their vision: visit their opthalmologist.
10/29/2013
To compare intraocular pressure (IOP) measurements obtained by rebound tonometry (Icare PRO tonometer)
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
Redressing Representation
Living with TED: My Race from Patient to Advocate
How Dry Eye Disease Impacts Younger Patients
The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: